ZAP70

Patients with chronic lymphocytic leukemia have variable outcome. ZAP70 can predict patients who have aggressive disease and need aggressive therapy.

TAT:
Specimen Type:
Flowcytometry Single Test

Description

Patients with chronic lymphocytic leukemia have variable outcome. ZAP70 can predict patients who have aggressive disease and need aggressive therapy.

Reviews

There are no reviews yet.

Be the first to review “ZAP70”

Your email address will not be published. Required fields are marked *